Lead Optimization of Butyrolactone I as an Orally Bioavailable Antiallergic Agent Targeting FcγRIIB.

Details

Language :

English

ISSN :

00222623

Volume :

67

Issue :

9

Database :

Supplemental Index

Journal :

Journal of Medicinal Chemistry

Publication Type :

Academic Journal

Accession number :

177225046

Full Text :

https://doi.org/10.1021/acs.jmedchem.4c00354